REG - CVS Group plc - Transaction in Own Shares

CVSAnnouncement

19/12/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251219:nRSS2129Ma&default-theme=true

RNS Number : 2129M  CVS Group plc  19 December 2025

19 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 18 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").

 

 Date of purchase:                                    18/12/2025
 Aggregate number of Ordinary Shares purchased:       18,123
 Lowest price paid per share (GBp):                   1,248.00
 Highest price paid per share (GBp):                  1,268.00
 Volume weighted average price paid per share (GBp):  1,257.38

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,783,372 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,783,372 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has
repurchased 957,411 Ordinary Shares in aggregate at a weighted average price
of 1,217.39 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.

 

Individual transactions:

 

 Number of                   Transaction price (GBp share)  Time of                 Transaction        Trading Venue

 Ordinary Shares purchased                                  transaction (UK Time)   reference number

 307                         1250                           18/12/2025 08:09:43     1353937584130558   XLON
 102                         1254                           18/12/2025 08:37:43     1353937584133303   XLON
 8                           1254                           18/12/2025 08:37:43     1353937584133304   XLON
 453                         1254                           18/12/2025 08:37:43     1353937584133305   XLON
 609                         1262                           18/12/2025 09:02:37     1353937584135463   XLON
 255                         1262                           18/12/2025 09:02:37     1353937584135464   XLON
 870                         1264                           18/12/2025 09:10:39     1353937584135960   XLON
 228                         1264                           18/12/2025 09:16:40     1353937584136294   XLON
 869                         1262                           18/12/2025 09:30:28     1353937584137015   XLON
 760                         1262                           18/12/2025 09:30:28     1353937584137016   XLON
 72                          1258                           18/12/2025 09:33:10     1353937584137105   XLON
 174                         1260                           18/12/2025 09:57:19     1353937584138818   XLON
 80                          1258                           18/12/2025 09:57:19     1353937584138822   XLON
 70                          1262                           18/12/2025 10:14:15     1353937584139761   XLON
 106                         1260                           18/12/2025 11:06:58     1353937584142803   XLON
 81                          1258                           18/12/2025 11:38:14     1353937584143948   XLON
 146                         1258                           18/12/2025 11:38:14     1353937584143951   XLON
 105                         1254                           18/12/2025 11:45:05     1353937584144245   XLON
 727                         1252                           18/12/2025 11:49:35     1353937584144455   XLON
 328                         1252                           18/12/2025 11:49:39     1353937584144460   XLON
 101                         1252                           18/12/2025 11:49:51     1353937584144475   XLON
 774                         1252                           18/12/2025 11:49:54     1353937584144486   XLON
 900                         1250                           18/12/2025 11:51:00     1353937584144598   XLON
 908                         1254                           18/12/2025 11:59:04     1353937584144923   XLON
 908                         1254                           18/12/2025 11:59:04     1353937584144932   XLON
 901                         1250                           18/12/2025 12:00:26     1353937584145643   XLON
 429                         1250                           18/12/2025 12:02:30     1353937584147471   XLON
 376                         1250                           18/12/2025 12:02:30     1353937584147473   XLON
 590                         1250                           18/12/2025 12:05:55     1353937584147883   XLON
 622                         1248                           18/12/2025 12:07:00     1353937584148033   XLON
 87                          1248                           18/12/2025 12:07:00     1353937584148034   XLON
 300                         1248                           18/12/2025 12:13:16     1353937584149101   XLON
 869                         1258                           18/12/2025 13:44:50     1353937584156800   XLON
 376                         1262                           18/12/2025 14:29:32     1353937584160096   XLON
 100                         1260                           18/12/2025 14:30:01     1353937584160298   XLON
 793                         1268                           18/12/2025 14:55:35     1353937584164955   XLON
 275                         1268                           18/12/2025 14:55:35     1353937584164956   XLON
 275                         1264                           18/12/2025 15:07:55     1353937584166713   XLON
 267                         1264                           18/12/2025 15:21:43     1353937584168395   XLON
 100                         1264                           18/12/2025 15:21:43     1353937584168397   XLON
 192                         1264                           18/12/2025 15:41:00     1353937584171506   XLON
 144                         1264                           18/12/2025 15:41:00     1353937584171507   XLON
 201                         1264                           18/12/2025 16:03:50     1353937584175041   XLON
 198                         1264                           18/12/2025 16:03:54     1353937584175064   XLON
 6                           1268                           18/12/2025 16:19:05     1353937584177834   XLON
 258                         1268                           18/12/2025 16:22:43     1353937584178435   XLON
 32                          1268                           18/12/2025 16:22:43     1353937584178436   XLON
 25                          1268                           18/12/2025 16:22:43     1353937584178437   XLON
 549                         1268                           18/12/2025 16:22:43     1353937584178438   XLON
 217                         1266                           18/12/2025 16:23:21     1353937584178537   XLON

 

 

Contacts

CVS Group
plc
via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
 
           +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint
Broker)
                +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)
 
                                 cvsg@camarco.co.uk

Ginny
Pulbrook
+44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia.  CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGPGMPPUPAUUB



            Copyright 2019 Regulatory News Service, all rights reserved